LB Pharmaceuticals (LBRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.30B and a free-cash-flow yield of -10.9%. Nama's AI scorecard rates it Sell, 2.7 out of 10. On 12-month momentum it ranks in the leading band of its market.
AI scorecard
Sell · 2.7/10
Clearly negative, short of the bottom band. As of Nov 20, 2026.
Momentum
Leading · +148.4% over 12 months ex. last
Top 20% of its market on the past year's steady rise.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-22.6%
How far the last close sits under the highest price of the past five years.
Market cap
$1.30B
Trailing P/E
—
Price / book
3.1
Price / sales
—
FCF yield
-10.9%
Dividend yield
—
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Revenue growth (YoY)
—
Revenue growth (3-yr annual)
—
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Beta
—
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
LBRX earnings
Next report: Mar 25, 2027 (Q4 2026, EPS estimate -$1.84).
Beat the EPS estimate in 0 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Nov 5, 2026
-$1.79
-$1.60
-11.9%
$0
Q2 2026
Aug 11, 2026
-$1.71
-$0.80
-113.8%
$0
Q4 2025
Mar 26, 2026
-$0.45
-$0.32
-40.6%
$0
Q3 2025
Nov 6, 2025
-$0.61
-$0.28
-117.9%
$0
LBRX analyst price target
Median target $55.00 from 11 analysts, ranging $35.00 – $80.00.
Nama's AI scorecard currently rates LB Pharmaceuticals Sell (2.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does LBRX report earnings?
LB Pharmaceuticals's next scheduled report is on Mar 25, 2027. Analysts expect EPS of -$1.84.
What is the LBRX price target?
The median analyst price target from 11 analysts is $55.00, with a range of $35.00 – $80.00.
Is LBRX Shariah compliant?
Nama's AAOIFI-style screen reads LB Pharmaceuticals as Not Shariah Compliant. At least one of the three ratios or the industry test failed.